Oppenheimer & Co’s Ingevity NGVT Stock Holding History

Oppenheimer & Co’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,072	Closed	-$219K	–	1356
2019 Q1	$219K	Buy	+2,072	New	+$208K	0.01%	1185
2018 Q4	–	Sell	-2,272	Closed	-$231K	–	1326
2018 Q3	$231K	Buy	+2,272	New	+$219K	0.01%	1173

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oppenheimer & Co's NGVT Position: Q2 2019 in Review

Oppenheimer & Co sold out of Ingevity (NGVT) in Q2 2019, closing a stake of 2,072 shares — an estimated $219K sold.

Oppenheimer & Co first reported a position in NGVT in Q3 2018 and held it in 2 quarters. The position peaked at $231K in Q3 2018. 334 funds tracked by Wall St. Rank hold NGVT as of Q2 2019.

Oppenheimer & Co reported no remaining Ingevity position as of Q2 2019 after selling out during the quarter.
Oppenheimer & Co sold 2,072 Ingevity shares in Q2 2019, an estimated $219K.
Oppenheimer & Co first reported a position in Ingevity in Q3 2018 and held it in 2 quarters.
Oppenheimer & Co's Ingevity position peaked at $231K in Q3 2018.
334 funds tracked by Wall St. Rank held Ingevity as of Q2 2019.

Based on Oppenheimer & Co's 13F filing for Q2 2019, filed 9 Aug 2019.